Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-08-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥23.9bn2025-01-01 → 2025-06-30Cons.Net sales
Revenue¥47.1bn2024-01-01 → 2024-12-31Cons.Net sales (5-year summary)
Revenue¥22.4bn2024-01-01 → 2024-06-30Cons.Net sales
Operating income¥1.5bn2025-01-01 → 2025-06-30Cons.Operating income
Operating income¥1.5bn2024-01-01 → 2024-06-30Cons.Operating income
Ordinary income¥1.4bn2025-01-01 → 2025-06-30Cons.Ordinary income
Ordinary income¥3.6bn2024-01-01 → 2024-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.6bn2024-01-01 → 2024-06-30Cons.Ordinary income
Profit before tax¥1.6bn2025-01-01 → 2025-06-30Cons.Income before income taxes
Profit before tax¥1.6bn2024-01-01 → 2024-06-30Cons.Income before income taxes
Net income (owners)¥873m2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.0bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent
Net income¥981m2025-01-01 → 2025-06-30Cons.Profit loss
Net income¥1.1bn2024-01-01 → 2024-06-30Cons.Profit loss
Total assets¥55.5bnat 2025-06-30Cons.Assets
Total assets¥55.6bnat 2024-12-31Cons.Assets
Total assets¥54.7bnat 2024-06-30Cons.Total assets (5-year summary)
Total liabilities¥16.8bnat 2025-06-30Cons.Liabilities
Total liabilities¥17.0bnat 2024-12-31Cons.Liabilities
Net assets / equity¥38.7bnat 2025-06-30Cons.Net assets
Net assets / equity¥38.6bnat 2024-12-31Cons.Net assets
Net assets / equity¥37.9bnat 2024-06-30Cons.Net assets (5-year summary)
Cash and deposits¥10.3bnat 2025-06-30Cons.Cash and deposits
Cash and deposits¥10.6bnat 2024-12-31Cons.Cash and deposits
Cash & equivalents¥9.1bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥9.6bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥8.6bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.0bnat 2023-12-31vCons.Cash and cash equivalents
Operating cash flow¥1.6bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥3.7bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.6bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.3bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥899m2024-01-01 → 2024-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥807m2024-01-01 → 2024-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥380m2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.4bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥483m2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥24.092025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.182024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.562024-01-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio62.0%at 2025-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio61.5%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio61.3%at 2024-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E02296-000Control Systemreportable segmentrevenue2025-01-01 → 2025-06-30¥3.3bn
jpcrp040300-q2r_E02296-000Control Systemreportable segmentrevenue external2025-01-01 → 2025-06-30¥3.3bn
jpcrp040300-q2r_E02296-000Control Systemreportable segmentsegment profit2025-01-01 → 2025-06-30¥230m
jpcrp040300-q2r_E02296-000Fastenerreportable segmentrevenue2025-01-01 → 2025-06-30¥17.7bn
jpcrp040300-q2r_E02296-000Fastenerreportable segmentrevenue external2025-01-01 → 2025-06-30¥17.7bn
jpcrp040300-q2r_E02296-000Fastenerreportable segmentsegment profit2025-01-01 → 2025-06-30¥914m
jpcrp040300-q2r_E02296-000Machineryreportable segmentrevenue2025-01-01 → 2025-06-30¥2.8bn
jpcrp040300-q2r_E02296-000Machineryreportable segmentrevenue external2025-01-01 → 2025-06-30¥2.8bn
jpcrp040300-q2r_E02296-000Machineryreportable segmentsegment profit2025-01-01 → 2025-06-30¥418m
jpcrp040300-q2r_E02296-000Medicalreportable segmentrevenue2025-01-01 → 2025-06-30¥55m
jpcrp040300-q2r_E02296-000Medicalreportable segmentrevenue external2025-01-01 → 2025-06-30¥55m
jpcrp040300-q2r_E02296-000Medicalreportable segmentsegment profit2025-01-01 → 2025-06-30−¥56m
—segment totalrevenue2025-01-01 → 2025-06-30¥23.9bn
—segment totalrevenue external2025-01-01 → 2025-06-30¥23.9bn
—segment totalsegment profit2025-01-01 → 2025-06-30¥1.5bn
jpcrp040300-q2r_E02296-000Control Systemreportable segmentrevenue2024-01-01 → 2024-06-30¥3.2bn
jpcrp040300-q2r_E02296-000Control Systemreportable segmentrevenue external2024-01-01 → 2024-06-30¥3.2bn
jpcrp040300-q2r_E02296-000Control Systemreportable segmentsegment profit2024-01-01 → 2024-06-30¥328m
jpcrp040300-q2r_E02296-000Fastenerreportable segmentrevenue2024-01-01 → 2024-06-30¥16.0bn
jpcrp040300-q2r_E02296-000Fastenerreportable segmentrevenue external2024-01-01 → 2024-06-30¥16.0bn
jpcrp040300-q2r_E02296-000Fastenerreportable segmentsegment profit2024-01-01 → 2024-06-30¥691m
jpcrp040300-q2r_E02296-000Machineryreportable segmentrevenue2024-01-01 → 2024-06-30¥3.1bn
jpcrp040300-q2r_E02296-000Machineryreportable segmentrevenue external2024-01-01 → 2024-06-30¥3.1bn
jpcrp040300-q2r_E02296-000Machineryreportable segmentsegment profit2024-01-01 → 2024-06-30¥539m
jpcrp040300-q2r_E02296-000Medicalreportable segmentrevenue2024-01-01 → 2024-06-30¥6m
jpcrp040300-q2r_E02296-000Medicalreportable segmentrevenue external2024-01-01 → 2024-06-30¥6m
jpcrp040300-q2r_E02296-000Medicalreportable segmentsegment profit2024-01-01 → 2024-06-30−¥64m
—segment totalrevenue2024-01-01 → 2024-06-30¥22.4bn
—segment totalrevenue external2024-01-01 → 2024-06-30¥22.4bn
—segment totalsegment profit2024-01-01 → 2024-06-30¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 552
ItemContextValueUnit
Other information consolidated financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identityconsolidated 2025-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsconsolidated 2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass